Covington Investment Advisors Inc. Abb Vie Inc. Transaction History

Covington Investment Advisors Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $1.95 Million - $2.34 Million	-30,899 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $61,501 - $75,847	790 Added 2.62%	30,899 $2.85 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $73,350 - $81,543	-825 Reduced 2.67%	30,109 $2.85 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $3,591 - $4,249	40 Added 0.13%	30,934 $2.87 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $5,336 - $7,146	58 Added 0.19%	30,894 $2.92 Million
Q1 2017 Nov 02, 2017	BUY	N/A	30,836	30,836 $2.01 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Covington Investment Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Covington Investment Advisors Inc. with notifications on news.